breast adenocarcinoma
Showing 1 - 25 of 31
Breast Adenocarcinoma, Hormone Receptor Positive, Stage IA Breast Cancer AJCC v7 Trial in Worldwide (drug, other, radiation)
Active, not recruiting
- Breast Adenocarcinoma
- +6 more
- Anastrozole
- +6 more
-
Anniston, Alabama
- +1230 more
Jan 28, 2023
HER2-positive Breast Cancer, Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7 Trial in San Francisco (Neratinib,
Completed
- HER2-positive Breast Cancer
- +8 more
- Neratinib
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jan 6, 2023
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +6 more
- Biopsy
- +3 more
-
Jacksonville, FloridaMayo Clinic in Florida
Jan 6, 2023
Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial
Withdrawn
- Anatomic Stage 0 Breast Cancer AJCC v8
- +28 more
- Carbon Dioxide Fractional Laser
- Questionnaire Administration
- (no location specified)
Jan 5, 2023
Breast Adenocarcinoma, Invasive Breast Carcinoma, Resectable Breast Carcinoma Trial in Jacksonville (Biospecimen Collection,
Recruiting
- Breast Adenocarcinoma
- +2 more
- Biospecimen Collection
- Letrozole
-
Jacksonville, FloridaMayo Clinic in Florida
Jan 4, 2023
Gut Microbiome and Chemotherapy-Induced Nausea in Women
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +3 more
- Biospecimen Collection
- Questionnaire Administration
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jan 4, 2023
Breast Cancer, Node-positive Breast Cancer, Breast Adenocarcinoma Trial in Richmond, South Hill (External Beam Radiation
Active, not recruiting
- Breast Cancer
- +4 more
- External Beam Radiation Therapy
- +2 more
-
Richmond, Virginia
- +1 more
Dec 16, 2022
Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in
Recruiting
- Anatomic Stage 0 Breast Cancer AJCC v8
- +23 more
- Quality-of-Life Assessment
- +2 more
-
Jacksonville, FloridaMayo Clinic in Florida
Nov 9, 2022
Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7 Trial in United States
Recruiting
- Breast Adenocarcinoma
- +7 more
- Multi-epitope HER2 Peptide Vaccine TPIV100
- +5 more
-
Scottsdale, Arizona
- +26 more
Aug 17, 2022
Advanced Solid Tumor, Metastatic Cancer, Refractory Cancer Trial in Huntersville, Houston, Webster (PT199, Anti-PD-1 mAb)
Recruiting
- Advanced Solid Tumor
- +18 more
- PT199
- Anti-PD-1 monoclonal antibody
-
Huntersville, North Carolina
- +2 more
Aug 10, 2022
Breast Adenocarcinoma, Invasive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States (drug, biological, other)
Active, not recruiting
- Breast Adenocarcinoma
- +9 more
- Entinostat
- +4 more
-
Duarte, California
- +4 more
Jul 16, 2022
MRI Scans in People Who Have Breast Tissue Expanders After
Recruiting
- Breast Cancer
- +2 more
- MRI Studies
- Patient Reported Outcomes
-
Montvale, New Jersey
- +2 more
May 31, 2022
Breast Adenocarcinoma, HER2/Neu Negative, Invasive Breast Carcinoma Trial in United States (Eribulin Mesylate, Laboratory
Suspended
- Breast Adenocarcinoma
- +4 more
- Eribulin Mesylate
- +3 more
-
Scottsdale, Arizona
- +38 more
May 25, 2022
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +22 more
- Microbiota-based Formulation RBX7455
-
Jacksonville, FloridaMayo Clinic in Florida
May 12, 2022
Breast Cancer, Breast Cancer Female, Breast Adenocarcinoma Trial in Tampa (Standard of Care Schedule Variation: SABR,
Terminated
- Breast Cancer
- +2 more
- Standard of Care Schedule Variation: SABR
- Breast-conserving Surgery
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Apr 26, 2022
Metastatic Breast Adenocarcinoma, Metastatic HER2-Positive Breast Carcinoma, Recurrent Breast Adenocarcinoma Trial in Canada,
Recruiting
- Breast Adenocarcinoma
- +8 more
- Atezolizumab
- +6 more
-
Birmingham, Alabama
- +667 more
Apr 6, 2022
Breast Cancer, Breast Adenocarcinoma, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Trial in Bronx (Rebastinib,
Terminated
- Breast Cancer
- +4 more
- Rebastinib
- +2 more
-
Bronx, New YorkMontefiore Medical Center
Mar 23, 2022
HER2-positive Breast Cancer, Recurrent Breast Cancer, Stage IIA Breast Cancer Trial in Duarte, Lancaster, South Pasadena
Active, not recruiting
- HER2-positive Breast Cancer
- +9 more
- pertuzumab
- +3 more
-
Duarte, California
- +2 more
Mar 17, 2022
Breast Adenocarcinoma, Metastatic Triple-Negative Breast Carcinoma, Stage III Breast Cancer AJCC v7 Trial in Jacksonville (drug,
Active, not recruiting
- Breast Adenocarcinoma
- +6 more
- Binimetinib
- +2 more
-
Jacksonville, FloridaMayo Clinic in Florida
Dec 14, 2021
Breast Adenocarcinoma, Ductal Breast Carcinoma In Situ, Invasive Breast Carcinoma Trial in Houston (Accelerated Partial Breast
Recruiting
- Breast Adenocarcinoma
- +9 more
- Accelerated Partial Breast Irradiation
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 21, 2021
Breast Adenocarcinoma, HER2/Neu Negative, Locally Advanced Breast Carcinoma Trial in South Africa, United States (Entinostat,
Active, not recruiting
- Breast Adenocarcinoma
- +9 more
- Entinostat
- +3 more
-
Birmingham, Alabama
- +662 more
Oct 18, 2021
Anti-HER2 Therapies in HER2-Positive Stage I-IV Breast Cancer
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +23 more
- Biospecimen Collection
-
Jacksonville, FloridaMayo Clinic in Florida
Aug 9, 2021